Prognostic factors and outcomes in minimal access resections of skull base and sinonasal epithelial malignancy.


Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
12 2022
Historique:
revised: 18 08 2022
received: 13 03 2022
accepted: 19 08 2022
pubmed: 8 9 2022
medline: 21 12 2022
entrez: 7 9 2022
Statut: ppublish

Résumé

Sinonasal epithelial malignancies are uncommon tumours but represent a challenge to treatment given their close proximity to the orbit, brain and cranial nerves. Traditional external surgical approaches have potential for significant functional and cosmetic morbidity. An endoscopic approach provides the surgeon with good access for tumour removal and enables surveillance postoperatively. This study aimed to assess outcomes of an endoscopic approach to sinonasal epithelial malignancy and evaluate factors that may influence its utility. A case series was performed involving consecutive patients treated with endoscopic or endoscopic-assisted surgery for epithelial sinonasal malignancy. Stratification included TNM staging, histopathology, surgical approach, margin status, perineural involvement and adjuvant or neoadjuvant therapy. At follow-up, complications, local control, nodal status and evidence of distant metastases were recorded. Statistical analyses to identify risk factors for developing recurrence and survival differences were performed. Thirty-five patients were assessed in this study (59.2 ± 11.4 years, 42.9% female). T stage at presentation was T1 in 11.4%, T2 in 17.1%, T3 in 22.9% and T4 in 48.6%. The 3 and 5 year disease specific survival were 91.3% (SE 5) and 71.1% (SE 10). The only factors to influence survival outcomes were perineural invasion of tumour and positive margins at the time of initial surgery. Large tumours did not limit the utility of an endoscopic approach. Endoscopic approach is a safe and oncologically equitable treatment approach to external approaches in the management of epithelial sinonasal malignancy. As with external approaches, perineural invasion of malignance is a poor prognostic factor.

Sections du résumé

BACKGROUND
Sinonasal epithelial malignancies are uncommon tumours but represent a challenge to treatment given their close proximity to the orbit, brain and cranial nerves. Traditional external surgical approaches have potential for significant functional and cosmetic morbidity. An endoscopic approach provides the surgeon with good access for tumour removal and enables surveillance postoperatively. This study aimed to assess outcomes of an endoscopic approach to sinonasal epithelial malignancy and evaluate factors that may influence its utility.
METHODS
A case series was performed involving consecutive patients treated with endoscopic or endoscopic-assisted surgery for epithelial sinonasal malignancy. Stratification included TNM staging, histopathology, surgical approach, margin status, perineural involvement and adjuvant or neoadjuvant therapy. At follow-up, complications, local control, nodal status and evidence of distant metastases were recorded. Statistical analyses to identify risk factors for developing recurrence and survival differences were performed.
RESULTS
Thirty-five patients were assessed in this study (59.2 ± 11.4 years, 42.9% female). T stage at presentation was T1 in 11.4%, T2 in 17.1%, T3 in 22.9% and T4 in 48.6%. The 3 and 5 year disease specific survival were 91.3% (SE 5) and 71.1% (SE 10). The only factors to influence survival outcomes were perineural invasion of tumour and positive margins at the time of initial surgery. Large tumours did not limit the utility of an endoscopic approach.
CONCLUSION
Endoscopic approach is a safe and oncologically equitable treatment approach to external approaches in the management of epithelial sinonasal malignancy. As with external approaches, perineural invasion of malignance is a poor prognostic factor.

Identifiants

pubmed: 36069324
doi: 10.1111/ans.18022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3253-3258

Informations de copyright

© 2022 Royal Australasian College of Surgeons.

Références

Ansa B, Goodman M, Ward K et al. Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009. Cancer 2013; 119: 2602-10.
Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg. 1980; 2: 497-508.
Franchi A, Miligi L, Palomba A, Giovannetti L, Santucci M. Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications. Crit. Rev. Oncol. Hematol. 2011; 79: 265-77.
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012; 34: 877-85.
Youlden DR, Cramb SM, Peters S et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013; 37: 770-9.
Harvey RJ, Winder M, Parmar P, Lund V. Endoscopic skull base surgery for sinonasal malignancy. Otolaryngol. Clin. North Am. 2011; 44: 1081-140.
Lund V, Howard DJ, Wei WI. Endoscopic resection of malignant tumors of the nose and sinuses. Am. J. Rhinol. 2007; 21: 89-94.
Nicolai P, Schreiber A, Bolzoni Villaret A et al. Intestinal type adenocarcinoma of the ethmoid: outcomes of a treatment regimen based on endoscopic surgery with or without radiotherapy. Head Neck 2016; 38: E996-E1003.
Vergez S, du Mayne MD, Coste A et al. Multicenter study to assess endoscopic resection of 159 sinonasal adenocarcinomas. Ann. Surg. Oncol. 2014; 21: 1384-90.
Harvey RJ, Nalavenkata S, Sacks R et al. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma. Head Neck 2017; 39: 2425-32.
Wang EW, Zanation AM, Gardner PA et al. ICAR: endoscopic skull-base surgery. Int. Forum Allergy Rhinol. 2019; 9: S145-365.
Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 1995; 105: 178-83.
Harvey RJ, Sheahan PO, Schlosser RJ. Surgical management of benign sinonasal masses. Otolaryngol. Clin. North Am. 2009; 42: 353-75.
Choussy O, Ferron C, Vedrine PO et al. Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 2008; 118: 437-43.
de Gabory L, Maunoury A, Maurice-Tison S et al. Long-term single-center results of management of ethmoid adenocarcinoma: 95 patients over 28 years. Ann. Surg. Oncol. 2010; 17: 1127-34.
Kilic S, Kilic SS, Baredes S et al. Comparison of endoscopic and open resection of sinonasal squamous cell carcinoma: a propensity score-matched analysis of 652 patients. Int. Forum Allergy Rhinol. 2018; 8: 421-34.
Karligkiotis A, Lepera D, Volpi L et al. Survival outcomes after endoscopic resection for sinonasal squamous cell carcinoma arising on inverted papilloma. Head Neck 2016; 38: 1604-14.
Kilic S, Kilic SS, Baredes S, Liu JK, Eloy JA. Survival, morbidity, and quality-of-life outcomes for sinonasal and ventral skull base malignancies. Otolaryngol. Clin. North Am. 2017; 50: 467-80.
Meccariello G, Deganello A, Choussy O et al. Endoscopic nasal versus open approach for the management of sinonasal adenocarcinoma: a pooled-analysis of 1826 patients. Head Neck 2016; 38: E2267-74.
Beswick DM, Hwang PH, Adappa ND et al. Surgical approach is associated with complication rate in sinonasal malignancy: a multicenter study. Int. Forum Allergy Rhinol. 2021; 11: 1617-25.
Battaglia P, Turri-Zanoni M, De Bernardi F et al. Septal flip flap for anterior skull base reconstruction after endoscopic resection of sinonasal cancers: preliminary outcomes. Acta Otorhinolaryngol. Ital. 2016; 36: 194-8.
Chin D, Harvey RJ. Endoscopic reconstruction of frontal, cribiform and ethmoid skull base defects. Adv Otorhinolaryngol. 2013; 74: 104-18.
Harvey RJ, Malek J, Winder M et al. Sinonasal morbidity following tumour resection with and without nasoseptal flap reconstruction. Rhinology 2015; 53: 122-8.
Harvey RJ, Sheahan PO, Schlosser RJ. Inferior turbinate pedicle flap for endoscopic skull base defect repair. Am. J. Rhinol. Allergy 2009; 23: 522-6.
Lai LT, Trooboff S, Morgan MK, Harvey RJ. The risk of meningitis following expanded endoscopic endonasal skull base surgery: a systematic review. J. Neurol. Surg. B Skull Base 2014; 75: 18-26.

Auteurs

Peta-Lee Sacks (PL)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, New South Wales, Australia.

Raquel Alvarado (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, New South Wales, Australia.

Raymond Sacks (R)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
The University of Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Department of Otolaryngology, Concord General Hospital, Sydney, New South Wales, Australia.

Larry Kalish (L)

The University of Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Department of Otolaryngology, Concord General Hospital, Sydney, New South Wales, Australia.

Raewyn Campbell (R)

Department of Otolaryngology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Richard Harvey (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
Department of Otolaryngology/Skull Base Surgery, St Vincent's Hospital, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH